These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 27102854)

  • 41. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.
    von Wartburg M; Raymond V; Paradis PE
    Int J Clin Pract; 2014 May; 68(5):639-46. PubMed ID: 24472120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors influencing the consumption of alcohol and tobacco: the use and abuse of economic models.
    Godfrey C
    Br J Addict; 1989 Oct; 84(10):1123-38. PubMed ID: 2819271
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Permissive nicotine regulation as a complement to traditional tobacco control.
    Sumner W
    BMC Public Health; 2005 Feb; 5():18. PubMed ID: 15730554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beyond Wishful Thinking: Integrating Consumer Preferences in the Assessment of Dietary Recommendations.
    Irz X; Leroy P; Réquillart V; Soler LG
    PLoS One; 2016; 11(6):e0158453. PubMed ID: 27362764
    [TBL] [Abstract][Full Text] [Related]  

  • 45. State of the art in benefit-risk analysis: consumer perception.
    Ueland Ø; Gunnlaugsdottir H; Holm F; Kalogeras N; Leino O; Luteijn JM; Magnússon SH; Odekerken G; Pohjola MV; Tijhuis MJ; Tuomisto JT; White BC; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):67-76. PubMed ID: 21683114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Accounting for "lost pleasure" in a cost-benefit analysis of government regulation: the case of the Food and Drug Administration's proposed cigarette labeling regulation.
    Chaloupka FJ; Gruber J; Warner KE
    Ann Intern Med; 2015 Jan; 162(1):64-5. PubMed ID: 25322210
    [No Abstract]   [Full Text] [Related]  

  • 47. Cost-effectiveness analyses of health promotion programs: a case study of smoking prevention and cessation among Dutch students.
    Vijgen SM; van Baal PH; Hoogenveen RT; de Wit GA; Feenstra TL
    Health Educ Res; 2008 Apr; 23(2):310-8. PubMed ID: 17675649
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Similarities and differences between stakeholders' opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey.
    Vokó Z; Cheung KL; Józwiak-Hagymásy J; Wolfenstetter S; Jones T; Muñoz C; Evers SM; Hiligsmann M; de Vries H; Pokhrel S;
    Health Res Policy Syst; 2016 May; 14(1):38. PubMed ID: 27230485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tobacco Regulation and Cost-Benefit Analysis: How Should We Value Foregone Consumer Surplus?
    Levy HG; Norton EC; Smith JA
    Am J Health Econ; 2018; 4(1):1-25. PubMed ID: 29404381
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Demand for Cigarettes as Derived from the Demand for Weight Loss: A Theoretical and Empirical Investigation.
    Cawley J; Dragone D; Von Hinke Kessler Scholder S
    Health Econ; 2016 Jan; 25(1):8-23. PubMed ID: 25346511
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiovascular health and economic effects of smoke-free workplaces.
    Ong MK; Glantz SA
    Am J Med; 2004 Jul; 117(1):32-8. PubMed ID: 15210386
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Taxes, prices and illicit trade: the need for sound evidence.
    Chaloupka FJ
    Tob Control; 2014 May; 23(e1):e1-2. PubMed ID: 24876290
    [No Abstract]   [Full Text] [Related]  

  • 53. Reduced affordability of cigarettes and socio-economic inequalities in smoking continuation in Stakhanov, Ukraine, 2009.
    Leinsalu M; Stickley A; Kunst AE
    Eur J Public Health; 2015 Apr; 25(2):216-8. PubMed ID: 25070072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are lower income smokers more price sensitive?: the evidence from Korean cigarette tax increases.
    Choi SE
    Tob Control; 2016 Mar; 25(2):141-6. PubMed ID: 25430738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methodological issues in the social cost of gambling studies.
    Walker DM
    J Gambl Stud; 2003; 19(2):149-84. PubMed ID: 12766468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluating a collaborative smoking cessation intervention in primary care (ENTER): study protocol for a cluster-randomized controlled trial.
    Härter M; Bartsch AL; Egger N; König HH; Kriston L; Schulz H; Tiemann M; Brütt AL; Buchholz A
    Trials; 2015 Oct; 16():447. PubMed ID: 26452466
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The theory of Rational Addiction.
    Rogeberg O
    Addiction; 2020 Jan; 115(1):184-187. PubMed ID: 31785044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Using massive online choice experiments to measure changes in well-being.
    Brynjolfsson E; Collis A; Eggers F
    Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7250-7255. PubMed ID: 30914458
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Art and culture in the COVID-19 era: for a consumer-oriented approach.
    Radermecker AV
    SN Bus Econ; 2021; 1(1):4. PubMed ID: 34778811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Utility model of preventive behaviour.
    Cohen DR
    J Epidemiol Community Health; 1984 Mar; 38(1):61-5. PubMed ID: 6707564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.